The UCR accepts referrals from GPs, Hampshire hospitals, ambulance services, families, and patients themselves. It helps ...
As wildfire smoke becomes a growing public-health story in the Northeast, a first-of-its-kind study in Environmental Health ...
At a national conference in Patna, specialists highlighted a troubling trend: women are increasingly suffering from COPD. The ...
Arexvy is GSK’s adjuvanted recombinant vaccine designed to prevent lower respiratory tract disease (LRTD) caused by RSV. Initially approved for adults aged 60 and older, as well as those aged 50-59 ...
GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...
GSK secures FDA approval for its oral gonorrhoea drug as EMA backs expanded RSV vaccine and additional respiratory treatments ...
GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines ...
An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed seven new medicines for approval this ...
FLU is tearing through NHS hospitals ahead of Christmas, and Health Secretary Wes Streeting has sounded the alarm over ...
GSK expects the European Commission to decide on approvals for both depemokimab and Nucala in the first quarter of 2026. GSK shares were 0.1% higher at 1,822.50 pence each on Friday afternoon in ...
A new study published in npj Aging provides compelling evidence that untreated obstructive sleep apnea (OSA) accelerates ...
Priority Health, a nationally recognized nonprofit health plan serving more than 1.3 million members, has partnered with Kivo Health, a leading provider of AI-powered virtual pulmonary rehabilitation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback